All filters
Slidesets
Introduction Session 1 | John Ward, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Slidesets
Best practice talk - Myanmar | Khin Pyone Kyi, MBBS, DBact, MMedSc, PhD, FRCP
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Slidesets
Best practice talk - Rwanda | Constance Mukabatsinda, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Slidesets
Introduction Session 2 | Michael Ninburg
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Slidesets
Best Practice Talk; France | Sylvie Deuffic-Burban, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2018
Slidesets
Clinical Pharmacology of ARV Drugs | Mas Chaponda
Presented at:
Gulf HIV Clinical Forum 2018
Slidesets
HIV treatment failure: practical tips | Ali Elgalib
Presented at:
Gulf HIV Clinical Forum 2018
Slidesets
General lecture on HIV drug resistance | Ghassan Wali, MD, FRCP(C)
Presented at:
Gulf HIV Clinical Forum 2018
Slidesets
Abstract: Prevalence of neuropsychiatric conditions among HIV positive compared to HIV negative commercially insured individuals in 2017 NAFLD with dyslipidemia (#5) | Joshua Cohen, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Abstract: Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in a rapid initiation model of care for HIV-1 infection: Week 24 interim analysis of the DIAMOND study (#6) | Keith Dunn, PharmD, BCPS, AAHIVE
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Abstract: Initial viral load decline and response rates by baseline viral load strata with dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: Pooled results from the GEMINI studies (#7) | Michael Aboud
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Hispanic/Latino longitudinal cohort of HIV-seropositive women and neurological complications | Loyda Melendez, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Abstract: Rhesus macaque model of SIV/SHIV-Zika co-infection (#9) | Siddappa Byrareddy
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Development of protease inhibitors against norovirus and other emerging viruses | Ladislau Kovari
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Presentation of Gertrude Elion Distinguished Lecturer Award recipient | Rowena Johnston, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Opening remarks and presentation of Gertrude Elion Distinguished Lecturer Award | Raymond Schinazi, PhD, DSc
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
State of the Art Lecture: Molecular basis for HIV latency | Jonathan Karn, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Understanding barriers to HIV cure | Robert Siliciano, MD, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Gertrude Elion Distinguished Lecturer Award Lecture: Innovation with an Impact: Development of HIV and TB drugs | Paul Stoffels, MD
Presented at:
HIV DART and Emerging Viruses 2018